While co-occurrence of 19q loss and IDH1 mutations has been found to diminish the survival advantage conferred by the IDH1 mutation in low-grade glioma (45), nothing has been reported so far about IDH1 and 11p15 loss co-occurrence. Here, IDH1 is linked to central nervous system cancer.